CARTESIAN THERAPEUTICS, INC.
Profile
Company Names
CARTESIAN THERAPEUTICS, INC.
SELECTA BIOSCIENCES INC
Addresses
704 QUINCE ORCHARD RD, GAITHERSBURG, MD 20878
704 QUINCE OCHARD ROAD, GAITHERSBURG, MA 20878
704 QUINCE OCHARD ROAD, GAITHERSBURG, MD 20878
65 GROVE STREET, WATERTOWN, MA 02472
480 ARSENAL WAY, WATERTOWN, MA 02472
480 ARSENAL STREET, BUILDING ONE, WATERTOWN, MA 02472
Phone Numbers
617-923-1400
6179231400
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2007
State Incorporated:
MASSACHUSETTS
Total Amount Raised:
$423,610,493.00
Number of Funding Rounds:
14
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
14
2024-07-02
$130,023,000.00
$130,023,000.00
$0.00
Equity
13
2023-11-13
$60,250,000.00
$60,250,000.00
$0.00
12
2020-07-31
$25,000,000.00
$25,000,000.00
$0.00
Equity
11
2019-12-18
$70,000,000.00
$70,000,000.00
$0.00
Equity
10
2019-08-20
$5,752,495.00
$5,752,495.00
$0.00
Equity
9
2017-06-27
$50,000,000.00
$50,000,000.00
$0.00
Equity
8
2016-12-02
$4,999,984.00
$4,999,984.00
$0.00
Equity
7
2015-08-27
$37,400,000.00
$40,637,943.00
$3,237,943.00
Equity
6
2015-04-10
$5,942,306.00
$7,500,000.00
$1,557,694.00
Debt
5
2014-08-14
$4,450,000.00
$4,450,000.00
$0.00
Equity
4
2014-07-15
$6,000,000.00
$6,000,000.00
$0.00
Equity
3
2014-04-07
$5,292,702.00
$9,999,994.00
$4,707,292.00
Equity
2
2011-11-07
$3,500,000.00
$26,000,000.00
$22,500,000.00
Equity
1
2010-03-22
$15,000,006.00
$15,000,006.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID
ABRAHAM
EXECUTIVE OFFICER
GORAN
ANDO
DIRECTOR
TIMOTHY
BARABE
DIRECTOR
TIMOTHY
C.
BARABE
DIRECTOR
WERNER
CAUTREELS
EXECUTIVE OFFICER, DIRECTOR
DOUGLAS
COLE
DIRECTOR
NISHAN
DE SILVA
DIRECTOR
OMID
FAROKHZAD
DIRECTOR
CARL
GORDON
DIRECTOR
FARALLON BIOSCIENCES, INC
| AMNIS CORP
| IGENICA INC
| ACCELERON PHARMA INC
| ARAGON PHARMACEUTICALS, INC.
| GOOD START GENETICS, INC.
| ARSANIS, INC.
| SINGULEX INC
| SELECTA BIOSCIENCES INC
| IGENICA BIOTHERAPEUTICS, INC
| COMPASS THERAPEUTICS LLC
| ADICET BIO, INC.
| INTELLIA THERAPEUTICS, INC.
| ALECTOR LLC
| GEMINI THERAPEUTICS, INC.
| SPRINGWORKS THERAPEUTICS, LLC
| PREVAIL THERAPEUTICS INC.
| THESEUS PHARMACEUTICALS, INC.
| TP THERAPEUTICS, INC.
| KUMQUAT BIOSCIENCES INC
| PASSAGE BIO, INC.
| KEROS THERAPEUTICS, INC.
| ADARX PHARMACEUTICALS, INC.
| BLOSSOMHILL THERAPEUTICS, INC.
| SCRIBE THERAPEUTICS, INC.
| GARUDA THERAPEUTICS, INC.
| ODYSSEY THERAPEUTICS, INC.
| ALTEROME THERAPEUTICS, INC.
| AVENZO THERAPEUTICS, INC.
| MBX BIOSCIENCES, INC.
| ARRIVENT BIOPHARMA, INC.
| BELENOS BIOSCIENCES, INC.
| LOMOND THERAPEUTICS HOLDINGS, INC.
| STAR THERAPEUTICS LLC
CARL
L.
GORDON
DIRECTOR
CADUCEUS PRIVATE INVESTMENTS IV, LP
| AMARIN CORP PLC\UK
| SELECTA BIOSCIENCES INC
| CADUCEUS CAPITAL II, L.P.
| CADUCEUS CAPITAL, L.P.
| ORBIMED ISRAEL PARTNERS LIMITED PARTNERSHIP
| ACCELERON PHARMA INC
| SINGULEX INC
| SINGULEX, INC.
| ORBIMED PARTNERS II, L.P.
| ORBIMED PARTNERS, L.P.
| ORBIMED PRIVATE INVESTMENTS V, LP
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| ORBIMED ROYALTY OPPORTUNITIES II, LP
| ORBIMED ASIA PARTNERS III, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES III, LP
| ORBIMED GENESIS FUND, L.P.
| ORBIMED NEW HORIZONS FUND, L.P.
| COMPASS THERAPEUTICS, INC.
| ORBIMED ASIA PARTNERS IV, L.P.
| ORBIMED ASIA PARTNERS V, L.P.
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP
| ORBIMED RCO IV OFFSHORE FEEDER, LP
| ORBIMED PRIVATE INVESTMENTS IX, LP
| ORBIMED RCO V OFFSHORE FEEDER, LP
| ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
| ORBIMED ASIA PARTNERS VI, L.P.
PETER
BARTON
HUTT
DIRECTOR
BIND BIOSCIENCES INC
| SELECTA BIOSCIENCES INC
| BLEND BIOSCIENCES, INC.
| Q HOLDINGS, INC.
| BLEND THERAPEUTICS, INC.
| BIND BIOSCIENCES, INC
| LIVING PROOF INC
| SERES HEALTH, INC.
| FLEX PHARMA, INC.
| PRONUTRIA BIOSCIENCES, INC.
| SUNEVA MEDICAL INC.
| AXCELLA HEALTH INC.
| WHOLE BIOME INC.
| RUBIUS THERAPEUTICS, INC.
| CEREHEALTH CORP
| ATELERIX LIFE SCIENCES INC.
| COLABS INT-L, CORP.
EDWIN
M.
KANIA, JR.
DIRECTOR
ROBERT
LANGER
DIRECTOR
MICROCHIPS, INC.
| ARSENAL MEDICAL, INC.
| ALSERES PHARMACEUTICALS INC /DE
| ECHO THERAPEUTICS, INC.
| MICELL TECHNOLOGIES INC
| CERULEAN PHARMA INC.
| HUMACYTE INC
| COMBINENT BIOMEDICAL SYSTEMS, INC.
| TARIS BIOMEDICAL INC
| KALA PHARMACEUTICALS, INC.
| FIBROCELL SCIENCE, INC.
| PREDICTIVE BIOSCIENCES, INC
| SEVENTH SENSE BIOSYSTEMS, INC.
| T2 BIOSYSTEMS, INC.
| SEMPRUS BIOSCIENCES CORP
| LIQUIDX, INC.
| ARSENAL VASCULAR, INC.
| ARSENAL MEDICAL, INC.
| SELECTA BIOSCIENCES INC
| STEMNION, INC.
| 480 BIOMEDICAL, INC.
| LIVING PROOF INC
| DX BIOSCIENCES, INC.
| MODERNA LLC
| HUMACYTE, INC
| XTUIT PHARMACEUTICALS, INC.
| SQZ BIOTECHNOLOGIES CO
| NOVEOME BIOTHERAPEUTICS, INC.
| LYNDRA, INC.
| MODERNA THERAPEUTICS, INC.
| VERSEAU THERAPEUTICS, INC.
| FREQUENCY THERAPEUTICS, INC.
| SUONO BIO, INC.
| COMBINED THERAPEUTICS, INC.
| HUMACYTE, INC.
| SEER BIOSCIENCES, INC.
| LANDSDOWNE LABS, LLC
| LIKEMINDS, INC./DE
| TARVEDA THERAPEUTICS, INC.
| LUMINOPIA, INC.
| LYRA THERAPEUTICS, INC.
| ABPRO CORP
| GLYMPSE BIO, INC.
| EPIBONE, INC.
| TEAL BIO, INC.
| ZWI THERAPEUTICS, INC.
| LYNDRA THERAPEUTICS, INC.
| KENDALL CAPITAL PARTNERS I, L.P.
| BILAYER THERAPEUTICS, INC.
| XENTER, INC.
| VIVTEX CORP
| SYNTIS BIO, INC.
| OMNIPULSE BIOSCIENCES, INC.
ROBERT
S.
LANGER, JR.
DIRECTOR
SCOTT
MYERS
DIRECTOR
AMIR
NASHAT
DIRECTOR
PROMEDIOR INC
| AVILA THERAPEUTICS INC
| PERVASIS THERAPEUTICS INC
| FATE THERAPEUTICS INC
| BIND BIOSCIENCES INC
| SELECTA BIOSCIENCES INC
| POLARIS VENTURE PARTNERS VI, L.P.
| SUN CATALYTIX CORP
| RECEPTOS, INC.
| POLARIS ENTREPRENEURS- FUND VII, L.P.
| POLARIS PARTNERS VII, L.P.
| ATYR PHARMA INC
| AGBIOME, LLC
| METACRINE, INC.
| SCHOLAR ROCK LLC
| 1366 TECHNOLOGIES INC
| SOFREGEN MEDICAL INC.
| POLARIS ENTREPRENEURS- FUND VIII, L.P.
| SYROS PHARMACEUTICALS, INC.
| SCHOLAR ROCK HOLDING CORP
| CAMP4 THERAPEUTICS CORP
| MORPHIC HOLDING, LLC
| FREENOME HOLDINGS, INC.
| PRIMMUNE THERAPEUTICS, INC.
| MORPHIC HOLDING, INC.
AYMERIC
SALLIN
DIRECTOR
GEORGE
SIBER
DIRECTOR
MICHAEL
SINGER
DIRECTOR
EXACT SCIENCES CORP
| BRAINSCOPE COMPANY, INC.
| REACH PROS, INC.
| PG-ACP HOLDINGS, L.P.
| BEDROCAN CANNABIS CORP.
| CLEMENTIA PHARMACEUTICALS INC.
| AURORA CANNABIS INC
| PYPESTREAM INC.
| ANODYNE NANOTECH, INC.
| INSIGHT DHARMA, LLC
| PYKUS THERAPEUTICS, INC.
| CBI PARENT, L.P.
| INSIGHT GREEN PARTNERS, LLC
| METALITE RESOURCES INC.
| BIOPORTO A/S
| CARTESIAN THERAPEUTICS, INC.
| TEAL BIO, INC.
| SPEEDWAY HOLDINGS, L.P.
TIMOTHY
SPRINGER
DIRECTOR
TIMOTHY
A.
SPRINGER
DIRECTOR
PATRICK
ZENNER
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-07-02
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-07-31
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-12-18
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-08-20
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2017-06-27
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-12-02
